prod:prod_dcx-login
Better Infection Prevention with On-Demand Molecular Diagnostics
Better and faster answers from diagnostic tests enable clinicians to enhance treatment and infection prevention efforts.
Only Cepheid delivers these fast and accurate results so you can:
Get easy to interpret answers for more cost-effective patient management1
Improve implementation of infection prevention policies2
Support better clinical decisions to improve patient outcomes3
Reduce the number of surgical site infections by using targeted decolonization strategies4
Elevate antibiotic stewardship and reduce unnecessary therapy costs5
Minimize follow-up visits by optimizing treatment early6
Impact of Rapid Diagnostics
Shortened hospital length of stay by 2.5 days3
.png)
Decreased lethal bloodstream infections in patients by 36%3
Reduced time to effective therapy by 5 hours3
Video
10 Hammersmith Broadway
Traditional Sexual Health services are based in hospitals. 10 Hammersmith Broadway moves sexual health services from the hospital into the heart of a neighborhood, revolutionizing the way the clinic serves the needs of its community while creating a better path forward.
Video
Carbapenem Resistance: A Medical and Public Health Challenge
Video
10 Hammersmith Broadway
Traditional Sexual Health services are based in hospitals. 10 Hammersmith Broadway moves sexual health services from the hospital into the heart of a neighborhood, revolutionizing the way the clinic serves the needs of its community while creating a better path forward.
Webinars
Simplification of testing and treatment in the quest to eliminate hepatitis C infection
Globally, 71 million people are living with hepatitis C virus (HCV) infection, but the burden of HCV continues to increase. Between 2015 and 2030, WHO targets include reducing new HCV infections by 80% and HCV deaths by 65%, and increasing HCV diagnoses from <20% to 90% and the number of eligible persons receiving HCV treatment from <10% to 80%. To achieve these targets, targeted interventions are needed to enhance HCV testing, linkage to care, and treatment (“the HCV care cascade”). This presentation reviews available evidence on strategies that have been successfully used to enhance HCV testing, linkage to care.
More...
Early diagnosis of HIV and use of molecular Point-of-Care HIV testing as part of a comprehensive strategy to end HIV transmission
In this webinar, Dr. Larissa May discusses the diagnosis of sexually transmitted infections in the Emergency Department, the need for evidence-based medicine, and how same-visit treatment and management can be facilitated with on-demand testing for CT/NG.
More...
Antibiotic Stewardship in the Emergency Department
This webinar discusses the importance of diligent antimicrobial stewardship and accuracy of diagnostic tests for the detection of Group A Streptococcus pharyngitis. It provides commentary on the high confidence that molecular testing affords the antibiotic steward and how technology can reduce the practice of prescribing antibiotics "just-in-case" there is an infection, especially as testing moves closer to the patient.
More...
The Neglected STI: Trichomonas vaginalis
Among US women ages 14-49 the prevalence of Trichomonas vaginalis infection is estimated to be 2.3 million, though 85% of women found to have trichomoniasis report no symptoms. With varied complications such as increased risk of HSV-2/HIV acquisition, pelvic inflammatory disease and pre-term birth it has become increasingly important to identify and treat these patients quickly. This webinar will explore the renewed interest to screen and diagnose T. vaginalis in women. It will examine current testing methods available and provide updates regarding treatment options.
More...
Related Product Links
Xpert® Carba-R
Detection and differentiation of KPC, NDM, VIM, IMP-1, and OXA-48 in 50 minutes
Xpert® MRSA NxG
Active MRSA surveillance testing in around 70 minutes
Xpert® SA Nasal Complete
Pre-surgical S. aureus and MRSA in about 65 minutes
Xpert® MRSA/SA SSTI
Detect MRSA & SA skin and soft tissue infection in about one hour
Xpert® vanA/vanB
Rapid VRE screening for active outbreak prevention and control in around 48 minutes
Xpert® C. difficile BT
Detection of Clostridium difficile infection with an independent call-out of binary toxin and differentiation of the 027 strain in around 45 minutes
Xpert® MTB/RIF Ultra
Enhanced performance in detecting drug-sensitive and -resistant Tuberculosis in less than 80 minutes
Xpert® CT/NG
Fast and Accurate Diagnosis of Chlamydia and Gonorrhea
Xpert® TV
The First MolecularTrichomonas VaginalisTest for Both Women and Men
1.Casari E, et al. Reducing rates of Clostridium difficile infection by switching to a stand-alone NAAT with clear sampling criteria. Antimicrob Resist Infect Control. 2018;7:40.
2.Birgand G, et al. Rapid detection of glycopeptide-resistant enterococci: impact on decision-making and costs. Antimicrob Resist Infect Control. 2013 Nov 4;2(1):30.
3.Wenzler E, Using rapid diagnostics to fight resistance. Infectious Disease Special Edition. May 30, 2018. https://www.idse.net/Resistance--Stewardship/Article/09-15/Using-Rapid-
Diagnostics-to-Fight-Resistance/48730. Accessed 12 July 2018
4.Bauer KA, et al. An Antimicrobial Stewardship Program’s Impact with Rapid olymerase chain reaction methicillin-resistant/ Staphylococcus Blood Culture Test in Patients with Staphylococcus Bacteremia. ClinInfect Dis. 2010; 51(9):1074–1080.
5.Humphreys H, et al. Staphylococcus and surgical site infections: benefits of screening and decolonization before surgery. J Hosp Infect. 2016. Nov;94(3):295-304.
6.Rudd K, et al. Molecular Diagnostics Can Lead To Early Optimization of Antimicrobial Therapy for Staphylococcal Bacteremia: Experience at a Large Tertiary-Care VA Medical Center. Open Forum Infectious Diseases, Volume 3, Issue suppl_1, 1 December 2016, 1863. Accessed 12 July 2018.